The Centers for Disease Control and Prevention (CDC) recently updated vaccine guidance after its advisory committee recommended that all adults aged 75 years and older and adults aged 60–74 years who are at increased risk should receive a single dose of a respiratory syncytial virus (RSV) vaccine. The update reflects CDC’s intent to maximize RSV vaccination coverage among those most likely to benefit and to reduce implementation barriers associated with a previous recommendation that called for shared clinical decision-making. As of this spring, between 20% and 25% of people over age 60 were estimated to have received an RSV vaccine.
No need to scramble: A few weeks ago, officials noted that an ample supply of the RSV vaccine should be available this fall and did not expect shortages similar to what was experienced last year during the respiratory virus peak season. Read more about the decision to ration the vaccine from the JUCM archives: New RSV Vaccine Recommended For Rationing by CDC
Read More
- COVID-19 and RSV: Coinfection Requiring Hospitalization
- A 60-year old Male with Dyspnea and Hypoxemia at the Start of a Global Pandemic
- Treating Common Upper Respiratory Tract Infections in an Era of Increasing Antibiotic Resistance
- RSV Rates Doubled During 2022-2023 Flu Season